These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8994768)

  • 1. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol.
    Wasan KM; Conklin JS
    Clin Infect Dis; 1997 Jan; 24(1):78-80. PubMed ID: 8994768
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungals and renal safety--getting the balance right.
    Saliba F
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():21-4. PubMed ID: 16704922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B lipid complex.
    Rapp RP; Gubbins PO; Evans ME
    Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of amphotericin B and its derivatives].
    Vetkina IF
    Antibiot Khimioter; 1991 Apr; 36(4):36-8. PubMed ID: 1892433
    [No Abstract]   [Full Text] [Related]  

  • 5. A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment.
    Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Mahi L; Deray G
    Nephrol Dial Transplant; 2007 Oct; 22(10):3090-1. PubMed ID: 17595189
    [No Abstract]   [Full Text] [Related]  

  • 6. Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patients.
    Hall P; Kennedy G; Morton J; Hill GR; Durrant S
    Intern Med J; 2005 Jun; 35(6):374. PubMed ID: 15892774
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats.
    LeBrun M; Grenier L; Bergeron MG; Thibault L; Labrecque G; Beauchamp D
    Antimicrob Agents Chemother; 1999 Mar; 43(3):520-4. PubMed ID: 10049261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria lowers the risk of amphotericin B-associated hypokalaemia.
    Mohan S; Ahmed S; Alimohammadi B; Jaitly M; Cheng JT; Pogue VA
    J Antimicrob Chemother; 2007 Sep; 60(3):690-3. PubMed ID: 17597057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of nephrotoxicity associated with amphotericin B deoxycholate.
    Johnson JR
    Clin Infect Dis; 2004 Jan; 38(2):303; author reply 306-7. PubMed ID: 14699469
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal impairment and amphotericin B formulations in patients with invasive fungal infections.
    Saliba F; Dupont B
    Med Mycol; 2008 Mar; 46(2):97-112. PubMed ID: 18324488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story].
    Azanza Perea JR; Barberán J
    Rev Esp Quimioter; 2012 Mar; 25(1):17-24. PubMed ID: 22488537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse effects and safety of antimicrobial agents--nephrotoxicity].
    Sakamoto M
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():605-8. PubMed ID: 17455689
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 15. The population pharmacokinetics of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
    Amantea MA; Bowden RA; Forrest A; Working PK; Newman MS; Mamelok RD
    Chemotherapy; 1999 Jun; 45 Suppl 1():48-53. PubMed ID: 10394021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B.
    Bellmann R; Cleary JD; Sterba J
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-8. PubMed ID: 19537331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
    Makowsky MJ; Warkentin DI; Savoie ML
    Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of plasma lipids and lipoproteins in predicting amphotericin B-induced nephrotoxicity in pediatric oncology patients.
    Wasan KM; Wong JC; Corr T; Pritchard S
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):120-4. PubMed ID: 16094544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful living donor liver transplantation in a patient with preoperative fungal infection.
    Tsuchiya T; Abe T; Saito T; Sato Y; Kenjo A; Yamada F; Asari S; Nishi I; Tanaka K; Gotoh M
    Transplant Proc; 2003 Feb; 35(1):401. PubMed ID: 12591459
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.
    Vadiei K; Lopez-Berestein G; Luke DR
    Int J Obes; 1990 Jun; 14(6):465-72. PubMed ID: 2401582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.